Lung cancer: therapeutic guidelines for the surgeon. 2 out of 3 cases inoperable
Münchener Medizinische Wochenschrift 720(17): 572
1978
ISSN/ISBN: 0341-3098 PMID: 306560 Document Number: 130750
Document emailed within 1 workday
Related Documents
Felci, U.; Milani, F.; Musumeci, R.; Viganotti, G.; Zucali, R. 1971: Telecobalt therapy of inoperable lung neoplasms: 276 cases La Radiologia Medica 57(1): 56-62Behera, D.; Malik, S.K. 1984: Antitumor drugs in inoperable lung cancer Indian Journal of Chest Diseases and Allied Sciences 26(1): 60-61
Nemkova, E.V.; Mus, V.F. 2008: Use of radiochemotherapy for inoperable non-small cell lung cancer Voprosy Onkologii 54(1): 78-81
Pivniuk, V.M.; Kas'ianenko, I.V.; Pivniuk, N.A. 1987: The use of levamisole (decaris) in patients with inoperable lung cancer Voprosy Onkologii 33(5): 82-86
Conill, C.; Giralt, J.; Scherk, A.; Guerra, M.; Gili, J.; Salvador, L. 1986: Survival and prognostic factors in stage IIi inoperable cancer of the lung Medicina Clinica 87(5): 183-186
Masuda, N. 1997: Combination chemotherapy in the treatment of inoperable non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(Suppl 3): 379-383
Nagel, R. 1980: Practical limitations of a controlled multicenter therapeutic study with the example of advanced inoperable prostatic cancer Verhandlungen der Deutschen Gesellschaft für Innere Medizin 86: 1304-1316
Nishimura, M.; Sugiura, T.; Urata, A.; Ota, K. 1985: Current status in the treatment of inoperable non-small cell lung cancer (NSCLC) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 54-60
Gatzemeier, U.; Manegold, C.; Eberhard, W.; Wilke, H.J.; Chomy, F.; Chomy, P.; Khayat, D.; Blatter, J.; Seeber, S.; Drings, P. 1998: Ifosfamide and gemcitabine: a phase Ii trial in advanced inoperable non-small cell lung cancer Seminars in Oncology 25(1 Suppl 2: 15-18
Splinter, T.; Kok, T.; Kho, S.; Lameris, H.; ten Kate, F.; Dalesio, O.; Dolman, B.; Palmen, F.; Bouvy, J.; Burghouts, J. 1986: A multicenter phase Ii trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer Seminars in Oncology 13(3 Suppl 3: 97-103
Maneechawakajorn, J.; Benjawongsathien, D. 2014: Prognostic role of thyroid transcription factor-1 (TTF-1) in advanced and inoperable adenocarcinoma subtype of lung cancer among Thai patients Journal of the Medical Association of Thailand 97(Suppl 11): S11-S17
Fukuoka, M.; Takada, M.; Kamei, T.; Negoro, S.; Kusunoki, Y.; Matsui, K.; Ryu, S.; Sakai, N.; Takifuji, N.; Masuda, N. 1987: Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 2): 871-880
Valenti, S. 1973: Results of single- and multiple-drug treatment of 183 cases of inoperable bronchopulmonary cancer Polski Tygodnik Lekarski 28(14): 519-523
Decker, R.H.; Tanoue, L.T.; Colasanto, J.M.; Detterbeck, F.C.; Wilson, L.D. 2006: Evaluation and definitive management of medically inoperable early stage non-small-cell lung cancer. Part 2: newer treatment modalities Oncology 20(8): 899-905; Discussion: 905-908, 913
Manegold, C. 1998: Single-agent gemcitabine versus cisplatin/etoposide in patients with inoperable, locally advanced, or metastatic non-small cell lung cancer Seminars in Oncology 25(4 Suppl 9: 18-22
Tsujie, M.; Isono, S.; Sato, K.; Kawai, K.; Ikeda, M.; Hara, J.; Kitani, K.; Nakayama, T.; Fujiwara, Y.; Yukawa, M.; Watatani, M.; Inoue, M. 2013: Four cases of double bypass surgery involving choledochojejunostomy and gastrojejunostomy for inoperable peripancreatic head cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1890-1892
Boven, E.; Tierie, A.H.; Stam, J.; Pinedo, H.M. 1988: Combined radiation therapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer: results of a phase Ii trial Seminars in Oncology 15(6 Suppl 7: 18-19
Benhamou, A.C.; Acquaviva, P.; Zerez, A.; Castellani, L.; Alison, D. 1986: Peroperative endoluminal dilatation or recanalization (DELPO or RCPO) in arteriopathies of the lower extremities. a new therapeutic weapon for the vascular surgeon. Apropos of 42 cases Journal des Maladies Vasculaires 11(4): 379-387
2001: Guidelines for the treatment of lung cancer Duodecim; laaketieteellinen aikakauskirja 117(8): 894-908
Blair, C.; Butler, C.; Cotman, H.E.; Lloyd, R.; Lundell, D.; McMahon, L. 1977: Guidelines for management of lung cancer Arizona Medicine 34(3): 176-182